Price
No data yet.
Social Signal Score
Analyst Ratings
1 analystRevenue
$914.30M+64.35%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Wang Ying
- Sector
- Consumer Defensive
- Industry
- Tobacco
- Employees
- 897
- Beta
- 1.15
- Country
- CN
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 8.02
Financials
Revenue
$914.30M+64.4%Net Income
$217.13M+478.7%EBITDA
$130.01M+229.7%Free Cash Flow
$-63.23MEPS (diluted)
$0.17+551.3%Shares Outstanding (diluted)
1.31B-9.0%Operating Expenses
$226.81MCash & Debt
$8.97BReturn of Capital
$0.00Dividend per Share
$0.10Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $3.52B | $896.75M | $0.70 |
| 2024 | $2.44B | $551.84M | $0.45 |
| 2023 | $1.24B | $534.33M | $0.40 |
| 2022 | $5.33B | $1.44B | $1.09 |
| 2021 | $8.52B | $2.02B | $1.44 |
| 2020 | $3.82B | $-128.10M | $-0.08 |
| 2019 | $1.55B | $47.75M | $0.03 |
| 2018 | $132.61M | $-287.0K | $-0.00 |
Valuation
Project earnings forward and see what return today's price implies.
EPS was negative in at least one boundary year, so a compound growth rate can't be computed from it. Set your own assumption.
- EPS in 5 years
- $1.08
- Implied price
- $24.77
- Return from $1.71
- 70.7% a year
To earn 15.0% a year on these assumptions you'd need to buy at $12.31 — today's price is already 86.1% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 17 | 20 | 23 | 26 | 29 |
|---|---|---|---|---|---|
| -2.0% | 45.8% | 50.6% | 54.9% | 58.7% | 62.2% |
| 3.0% | 53.2% | 58.3% | 62.8% | 66.8% | 70.5% |
| 8.0% | 60.7% | 66.0% | 70.7% | 74.9% | 78.8% |
| 13.0% | 68.1% | 73.7% | 78.6% | 83.0% | 87.1% |
| 18.0% | 75.5% | 81.3% | 86.5% | 91.1% | 95.3% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
57-63.30%Social Signal Score
Mentions (4)
- Newsseekingalpha.com·16d ago·Neutral
RLX Technologies: Recent Share Price Weakness Provides Good Entry Point RLX Technology Inc. remains a BUY despite post-2Q26 margin compression, supported by strong growth forecasts and discounted valuation versus peers. RLX's international segment, now 70% of revenue, is boosted by recent European acquisitions, enhancing distribution and long-term growth prospects. Gross margins peaked in 2Q26 and are expected to normalize in 2H26 due to increased distributor participation and product mix shifts…
View source ↗ - Newsseekingalpha.com·52d ago·Positive
RLX Technology Inc. (RLX) Q2 2026 Earnings Call Transcript RLX Technology Inc. (RLX) Q2 2026 Earnings Call Transcript
View source ↗ - Newsmarketbeat.com·53d ago·Neutral
RLX Technology Q2 Earnings Call Highlights RLX Technology NYSE: RLX reported second-quarter 2026 revenue growth of 14.8% year over year, supported primarily by international expansion, while management outlined plans to deepen its European distribution footprint and broaden its portfolio of smoke-free products.
View source ↗ - Newsprnewswire.com·53d ago·Neutral
RLX Technology Announces Unaudited Second Quarter 2026 Financial Results SHENZHEN, China, Aug. 14, 2026 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE: RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Financial Highlights Net revenues were RMB1,010.5 million (US$148.9 million) in the second quarter of 2026, increasing by 14.8% from RMB880.0 million in the …
View source ↗
Earnings
Fri, Nov 13(in 5 weeks)
Consensus estimate $0.03 per share
Typical surprise -38.9% (median, so one quarter with a near-zero estimate can't distort it)
- Fri, Aug 14$0.03 vs $0.09miss
- Wed, May 20$0.03 vs $0.03miss
- Fri, Mar 13$0.03 vs $0.03miss
- Fri, Nov 14$0.02 vs $0.03miss
- Fri, Aug 22$0.02 vs $0.03miss
- Fri, May 16$0.02 vs $0.17miss
Estimates and results for RLX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by RLX officers and directors.
No open-market trades in the recent filings. All 17 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.
17 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in RLX.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.